Mindfulness-Based Therapies For Substance Use Disorders
Mindfulness-Based Therapies For Substance Use Disorders
Author Manuscript
Subst Abus. Author manuscript; available in PMC 2010 February 9.
Published in final edited form as:
NIH-PA Author Manuscript
The link between stress and addiction is well-known. Stress increases the likelihood of alcohol
and drug use, and can precipitate relapses following treatment (1). Clinicians and researchers
recognize the critical need to incorporate stress management techniques into inpatient and
NIH-PA Author Manuscript
outpatient treatment. The goal is to assist clients to replace substance use with healthy coping
skills when confronted with the inevitable stressors that threaten sobriety. Improved treatment
retention and relapse prevention are desired outcomes of the challenging search for evidenced-
based programs for recovering addicts.
This thematic issue of Substance Abuse is devoted to an emerging, promising area of research,
mindfulness meditation as a therapy for addictive disorders. Conceptual framework and
findings from a pilot-level research combined with an anecdotal evidence from clinical practice
support the use of this innovative therapy for a broad spectrum of substance use disorders and
mental health problems in general. If effective, mindfulness meditation based interventions
could help improve treatment outcomes in addictive disorders.
been implicated in substance abuse (11). Two studies showed that mindfulness meditation
limits experiential avoidance by promoting nonjudgmental acceptance of moment-to-moment
thoughts (12) and by interrupting the tendency to respond using maladaptive behaviors such
NIH-PA Author Manuscript
as substance use (3). Craving, too, may be ameliorated by mindfulness practice as one learns
not to react automatically but respond with awareness (13).
Although mindfulness meditation has been used in clinical settings as an adjunctive therapy
for substance abuse for a long time, there has been a relative paucity of research in this field.
When we ‘placed a call’ for papers focused on mindfulness based interventions targeting
substance abuse, we were surprised by many submissions from multiple authors from a variety
of clinical research settings around the world. Although this high turn-out has exceeded our
expectations, it highlights a growing interest in this clinical and research area. For this Special
Issue of Substance Abuse, we accepted 10 excellent papers. Half of these articles is assembled
in this issue, and the remaining 5 will be published in a subsequent issue of Substance Abuse.
The first paper by Zgierska and colleagues, “Mindfulness Meditation for Substance Use
Disorders: A Systematic Review”, is an extensive assessment of the clinical trial evidence of
the effects of mindfulness-based therapies on addictive disorders. The authors found that while
preliminary evidence suggests that mindfulness based interventions are efficacious, the data
are inclusive; they also provided useful directions for further research to assist scholars in
advancing the field.
NIH-PA Author Manuscript
The last two papers are derived from the same main study and report findings of cross-sectional
analyses of baseline (pre-cessation) data of 158 smokers enrolled in a.smoking cessation trial
comparing effects of MBSR to a standard of care treatment. Vidrine and colleagues examined
the “Associations of Mindfulness with Nicotine Dependence, Withdrawal and Agency,” and
found that mindfulness was negatively associated with the level of nicotine dependence and
NIH-PA Author Manuscript
“anticipatory” withdrawal severity, and positively associated with a sense of agency related to
cessation. In the same sample of individuals, Waters and colleagues evaluated “Associations
Between Mindfulness and Implicit Cognition and Self-reported Affect” and noted that degree
of mindfulness was negatively associated with severity of self-reported negative affect,
perceived stress and depressive symptoms, and positively associated with positive affect level.
Combined, these studies offer an intriguing glimpse into the continuing quest for appropriate
strategies to reduce stress and improve treatment outcomes in an especially vulnerable
population, individuals with substance use disorders. A forthcoming issue of Substance
Abuse will continue this theme with articles that look at effects of other mindfulness-based
interventions in a range of substance-abusing client populations. The papers in the second issue
will illustrate the ways in which mindfulness practice has been combined with other behavioral
treatments and/or adapted to meet the needs of specific client populations (14-18).
References
1. Sinha R. The role of stress in addiction relapse. Current Psychiatriatry Reports 2007;9(5):388–395.
NIH-PA Author Manuscript
2. Kabat-Zinn, J. Wherever you go there you are. Hyperion; New York: 1994. p. 4New York
3. Shapiro SL, et al. Mechanisms of mindfulness. Journal of Clinical Psychology 2006;62(3):373–386.
[PubMed: 16385481]
4. Teasdale JD, Segal Z, Williams JMG. How does cognitive therapy prevent depressive relapse and why
should control (mindfulness) training help? Behaviour Research and Therapy 1995;33:25–39.
[PubMed: 7872934]
5. Baer, RA.; Krietemeyer, J. Overview of mindfulness-and acceptance-based treatment approaches. In:
Baer, RA., editor. Mindfulness-based treatment approaches: Clinician’s guide to evidence base and
applications. Academic Press; New York, New York: 2006. p. 3-27.
6. Segal, Z.; Williams, JMG.; Teasdale, JD. Mindfulness-based cognitive therapy for depression: A new
approach to preventing relapse. Guilford; New York: 2002.
7. Linehan, MM. Cognitive-behavioral treatment of borderline personality disorder. Guilford Press; New
York: 1993.
8. Hayes SC. Acceptance, mindfulness, and science. Clinical Psychology: Science and Practice
2002;9:101–106.
9. Witkiewitz K, Marlatt GA, Walker D. Mindfulness-based relapse prevention for alcohol and substance
use disorders. Journal of Cognitive Psychotherapy 2005;19(3):211–228.
10. Marcus MT, et al. Mindfulness-based stress reduction in therapeutic community treatment: A stage
NIH-PA Author Manuscript